About: Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study
Creator	Jang, Insil Kim, Kyunghee Kim, Yuna
topic	covid:62219dc0553022e4faac2b1523e7e0a2d1eaec30#this
Source	PMC
abstract	Since the progression of cirrhosis is accelerated each time a complication recurs, the management and treatment of the complication is critical in enhancement of the quality of life and expectation of life in patients. The use of model for end-stage liver disease with incorporation of serum-sodium (MELD-Na) with physiological indicators can be used to assess severity and differentiate therapeutic interventions. This study is aimed to determine the mean survival period and cumulative survival rate by classifying patients into high-risk and low-risk groups based on MELD-Na, a predictor of mortality in liver disease, and to investigate the mortality prognostic factors. A retrospective cohort study, which follows the STROBE checklist, was performed. 263 patients who were diagnosed with liver cirrhosis complications for the first time and hospitalized were selected as the subjects of this study. The collected data were analyzed based on the survival package provided by the statistical program R version 3.4.2. Subjects were classified into high-risk and low-risk groups using MELD-Na 14 points where sensitivity and specificity crossed the cut-off point. Gender, age, and primary caregiver were significant variables in the mortality high-risk group, and AST, albumin, and primary caregiver were significant variables in the mortality low-risk group. Based on these mortality prognostic factors, it is possible to present the factors affecting mortality in patients who were diagnosed with liver cirrhosis complications for the first time. The classification of patients by risk level could be the foundation to provide accurate guidelines for management and it is necessary to modify prognostic factors and apply nursing interventions to manage complications.
has issue date	2019-11-11(xsd:dateTime)
bibo:doi	10.1097/md.0000000000017862
bibo:pmid	31702650
has license	cc-by-nc
sha1sum (hex)	62219dc0553022e4faac2b1523e7e0a2d1eaec30
schema:url	https://doi.org/10.1097/md.0000000000017862
resource representing a document's title	Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study
has PubMed Central identifier	PMC6855481
has PubMed identifier	31702650
schema:publication	Medicine (Baltimore)
resource representing a document's body	covid:62219dc0553022e4faac2b1523e7e0a2d1eaec30#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/62219dc0553022e4faac2b1523e7e0a2d1eaec30
is schema:about of	named entity 'LIVER CIRRHOSIS' named entity 'SERUM' named entity 'RECURS' named entity 'MANAGEMENT' named entity 'PHYSIOLOGICAL' named entity 'CRITICAL' named entity 'PROGRESSION' named entity 'SODIUM' named entity 'COMPLICATION' named entity 'ENHANCEMENT' named entity 'CIRRHOSIS' named entity 'PATIENTS' named entity 'THERAPEUTIC INTERVENTIONS' named entity 'ASSESS' named entity 'complication' named entity 'accelerated' named entity 'differentiate' named entity 'physiological' named entity 'CLASSIFICATION' covid:arg/62219dc0553022e4faac2b1523e7e0a2d1eaec30 named entity 'RETROSPECTIVE COHORT STUDY' named entity 'TREATMENT' named entity 'USED' named entity 'PROGNOSTIC FACTORS' named entity 'SODIUM' named entity 'ANALYSIS' named entity 'MORTALITY' named entity 'SEVERITY' named entity 'USE OF' named entity 'TIME' named entity 'QUALITY OF LIFE' named entity 'LIFE' named entity 'INDICATORS' named entity 'USING' named entity 'COMPLICATIONS' named entity 'DIFFERENTIATE' named entity 'SERUM' named entity 'MODEL FOR END-STAGE LIVER DISEASE' named entity 'EXPECTATION' named entity 'MODEL FOR END-STAGE LIVER DISEASE' named entity 'ACCELERATED' named entity 'life' named entity 'risk group' named entity 'prognosis' named entity 'Liver cirrhosis' named entity '13.5' named entity 'malignant tumor' named entity 'varicose veins' named entity 'cirrhosis' named entity 'hepatitis' named entity 'survival rate' named entity 'decompensated cirrhosis' named entity 'prognosis' named entity 'Kaplan-Meier' named entity 'bilirubin' named entity 'cirrhotic' named entity 'primary caregiver' named entity 'risk group' named entity 'survival rate' named entity 'liver cirrhosis' named entity 'primary caregiver' named entity 'AST' named entity 'Declaration of Helsinki' named entity 'primary caregiver' named entity 'cirrhosis' named entity 'Serum Sodium' named entity 'liver diseases' named entity 'cut-off' named entity 'cirrhosis' named entity 'Statistical Computing' named entity 'prognosis' named entity 'MELD' named entity 'descriptive statistics' named entity 'prognosis' named entity 'follow-up' named entity 'prognosis' named entity 'mortality risk'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software